비타민 B2시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 판매 채널, 최종 용도, 지역별 경쟁(2021-2031년)

The Global Vitamin B2 Market is forecasted to expand from USD 513.03 Million in 2025 to USD 666.95 Million by 2031, achieving a Compound Annual Growth Rate (CAGR) of 4.47%. Riboflavin, a vital water-soluble micronutrient, is crucial for energy metabolism, cellular processes, and the creation of other vitamins. This market's growth is primarily fueled by the increasing demand in the animal nutrition sector, where it serves as an indispensable feed additive for livestock health and development. Furthermore, heightened consumer interest in preventative healthcare is boosting the demand for dietary supplements and fortified food items. These foundational elements drive the market, separate from evolving trends such as the preference for biological fermentation production methods and clean label ingredients.

Nevertheless, the market faces considerable hurdles, largely stemming from the high concentration of manufacturing capabilities within specific regions. This geographical dependency creates significant supply chain vulnerabilities, often resulting in price instability when regulatory changes or logistical disruptions occur. This manufacturing dominance is underscored by figures like the approximately USD 11 million in Vitamin B2 exports from China in March 2024, as reported by the China Chamber of Commerce for Import and Export of Medicines and Health Products, emphasizing the critical role major production hubs play in maintaining global supply.

Market Driver

The escalating need for fortified animal feed additives acts as the primary catalyst for market expansion, given riboflavin's fundamental role as a micronutrient vital for livestock metabolism and efficient growth. Modern industrial agricultural practices, particularly within the poultry and swine industries, necessitate precise Vitamin B2 supplementation to prevent deficiency-related disorders and optimize feed conversion ratios. This intense reliance on fortified additives correlates directly with the steady expansion of the global feed industry, which aims to satisfy protein consumption requirements. According to Alltech's '2025 Agri-Food Outlook' in April 2025, global feed production volumes increased by 1.2% to 1.396 billion metric tons in 2024, confirming the consistent industrial demand for riboflavin.

Concurrently, the growth of the functional food and beverage sector serves as a robust secondary driver, propelled by heightened consumer awareness regarding energy metabolism and preventative healthcare. As individuals increasingly prioritize overall wellness, manufacturers are broadening their product portfolios to incorporate Vitamin B2 into sports nutrition and fortified snacks, recognizing its contribution to cellular energy production. WholeFoods Magazine reported in February 2025, based on CRN's 2024 Consumer Survey, that consumer usage of sports nutrition products-a key area for B-complex fortifications-climbed to 45% in 2024. This sustained end-user demand helps stabilize the market against broader supply chain fluctuations, with dsm-firmenich's Animal Nutrition & Health division alone generating over €3.3 billion in annual revenues in 2024, as noted in their Integrated Annual Report 2024, highlighting the financial scale of this ingredient-consuming sector.

Market Challenge

The Global Vitamin B2 Market faces substantial impediments due to the severe concentration of its manufacturing capacity within a single geographic region, which inherently creates acute vulnerabilities in the supply chain. This centralized production acts as a bottleneck, linking global availability inextricably to the operational stability of a limited number of major producers. Consequently, any local regulatory shifts, energy scarcities, or logistical interruptions in this primary manufacturing hub can swiftly trigger global shortages and sharp price volatility. Such uncertainty complicates the long-term procurement strategies for international buyers in the animal nutrition and pharmaceutical sectors, who frequently struggle to secure consistent supply contracts at stable rates, thereby restricting overall market stability and expansion.

The profound extent of this geographic reliance is clearly demonstrated by recent trade performance data, which highlights the sheer scale of the dominant production hub. For example, according to the China Chamber of Commerce for Import and Export of Medicines and Health Products, the export value of Western medicine raw materials-a sector heavily influenced by vitamin production-reached USD 11.1 billion in the first quarter of 2025. This heavy dependence on a solitary source region compels global stakeholders to absorb elevated risk premiums and manage fluctuating inventory levels, directly impeding consistent market growth.

Market Trends

The fortification of plant-based dairy alternatives represents a significant trend, involving the deliberate addition of riboflavin to non-dairy beverages to emulate the nutritional composition of traditional bovine milk. As consumers increasingly opt for substitutes like oat, almond, and soy varieties over conventional dairy, manufacturers are prompted to address the inherent deficiency of Vitamin B2 in these plant-derived sources to maintain product competitiveness and nutritional equivalence. This specific application demand is directly proportional to the commercial expansion of the plant-based sector, with brands increasingly emphasizing "complete nutrition" claims to attract and retain health-conscious consumers. The Good Food Institute's '2024 State of the Industry' report from April 2025 indicates that global retail sales of plant-based meat and dairy alternatives ascended to USD 28.6 billion in 2024, establishing a substantial and growing foundational requirement for riboflavin fortification in these formulated products.

Another transformative trend is the adoption of microencapsulation technologies, which are redefining the market by effectively addressing the intrinsic stability and taste issues associated with incorporating riboflavin into functional foods and advanced supplements. This innovative processing technique shields the vitamin from oxidation and light degradation while concurrently masking its naturally bitter flavor, thereby enabling its inclusion in a broader spectrum of delivery formats beyond conventional tablets. Furthermore, sophisticated encapsulation methods are now being utilized to manage precise release profiles for targeted health benefits, such as supporting the gut microbiome. Illustrating this technological progress, dsm-firmenich's 'Integrated Annual Report 2024' from February 2025 highlighted the launch of a new biotic vitamin solution that employs proprietary encapsulation to deliver 90% of the riboflavin directly to the colon, significantly improving its bioavailability compared to free forms.

Key Market Players

• Hubei Guangji Pharmaceutical Co., Ltd
• dsm-firmenich
• BASF SE
• Haijianuo Pharmaceutical Co., Ltd.
• Zhejiang Shengda Bio-Pharm Co Ltd.
• Shandong Hongda Biological Technology Co., Ltd.
• Xinfa Pharmaceutical Co. Ltd
• N.B Group Co. Ltd

Report Scope

In this report, the Global Vitamin B2 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin B2 Market, By Sales Channel

• Direct
• Indirect

Vitamin B2 Market, By End Use

• Animal feed
• Pharmaceuticals & Supplements
• Food & Beverage Fortification
• Colorant
• Others

Vitamin B2 Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B2 Market.

Available Customizations:

Global Vitamin B2 Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vitamin B2 Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Sales Channel (Direct, Indirect)
  • 5.2.2. By End Use (Animal feed, Pharmaceuticals & Supplements, Food & Beverage Fortification, Colorant, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Vitamin B2 Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Sales Channel
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vitamin B2 Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Sales Channel
      • 6.3.1.2.2. By End Use
  • 6.3.2. Canada Vitamin B2 Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Sales Channel
      • 6.3.2.2.2. By End Use
  • 6.3.3. Mexico Vitamin B2 Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Sales Channel
      • 6.3.3.2.2. By End Use

7. Europe Vitamin B2 Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Sales Channel
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Vitamin B2 Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Sales Channel
      • 7.3.1.2.2. By End Use
  • 7.3.2. France Vitamin B2 Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Sales Channel
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom Vitamin B2 Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Sales Channel
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Vitamin B2 Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Sales Channel
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Vitamin B2 Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Sales Channel
      • 7.3.5.2.2. By End Use

8. Asia Pacific Vitamin B2 Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Sales Channel
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Vitamin B2 Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Sales Channel
      • 8.3.1.2.2. By End Use
  • 8.3.2. India Vitamin B2 Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Sales Channel
      • 8.3.2.2.2. By End Use
  • 8.3.3. Japan Vitamin B2 Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Sales Channel
      • 8.3.3.2.2. By End Use
  • 8.3.4. South Korea Vitamin B2 Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Sales Channel
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia Vitamin B2 Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Sales Channel
      • 8.3.5.2.2. By End Use

9. Middle East & Africa Vitamin B2 Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Sales Channel
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Vitamin B2 Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Sales Channel
      • 9.3.1.2.2. By End Use
  • 9.3.2. UAE Vitamin B2 Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Sales Channel
      • 9.3.2.2.2. By End Use
  • 9.3.3. South Africa Vitamin B2 Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Sales Channel
      • 9.3.3.2.2. By End Use

10. South America Vitamin B2 Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Sales Channel
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Vitamin B2 Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Sales Channel
      • 10.3.1.2.2. By End Use
  • 10.3.2. Colombia Vitamin B2 Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Sales Channel
      • 10.3.2.2.2. By End Use
  • 10.3.3. Argentina Vitamin B2 Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Sales Channel
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Vitamin B2 Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Hubei Guangji Pharmaceutical Co., Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. dsm-firmenich
• 15.3. BASF SE
• 15.4. Haijianuo Pharmaceutical Co., Ltd.
• 15.5. Zhejiang Shengda Bio-Pharm Co Ltd.
• 15.6. Shandong Hongda Biological Technology Co., Ltd.
• 15.7. Xinfa Pharmaceutical Co. Ltd
• 15.8. N.B Group Co. Ltd

16. Strategic Recommendations

17. About Us & Disclaimer